pyramid-online.ru


MODERNA VALUE

GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. width= Moderna Inc's mRNA Drug. Enterprise Value/Market CapN/A. Enterprise Value/Revenue Enterprise Value/Gross Profit Enterprise Value/Ebitda Show more. Moderna Stock Smart. As of March Moderna has a market cap of $ Billion. This makes Moderna the world's th most valuable company by market cap according to our data. The. Interactive chart of historical stock value for Moderna over the last 10 years. The value of a company is typically represented by its market capitalization. There are M shares outstanding in Moderna Inc, which values the company at $ B. Is Moderna stock a Buy, Sell or Hold? Moderna stock has received a.

Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. In depth view into Moderna Enterprise Value including historical data from , charts and stats. Moderna Inc MRNA:NASDAQ ; Close. quote price arrow up + (+%) ; Volume. 4,, ; 52 week range. - Moderna Market Cap. Moderna has a market cap or net worth of $ billion as of March 1, Its market cap has decreased by % in one year. Flawless balance sheet and good value. Data Learn. Rewards. Trading at % below our estimate of its fair value · Revenue is forecast to grow % per year. Moderna, Inc. Common Stock (MRNA). Nasdaq Listed Value. Exchange, NASDAQ-GS. Sector, Health Care Moderna is a commercial-stage biotech that was founded in. Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with. value=) compared with KEYTRUDA alone. In June, the Company announced a statistically significant and clinically meaningful improvement in distant. Investing Groups Covering MRNA. Chris Lau · DIY Value Investing · Chris Lau · Latest on MRNA: Special Report: Sell Before The Rug Pull And Buy These Market Value, $B. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. Ex-Dividend Date, N/A. Access detailed information about the Moderna Fair Value. Unlock. Dividends Payment Streak. Unlock. Show More Moderna Inc News · Moderna to hold annual.

A ratio used to determine if a company's market value is in line with the value of its assets less liabilities and preferred stock. , —. Return on assets. A. Fair Value. pyramid-online.ru Overvalued. Subscribe to Yahoo Finance Plus to view Fair Moderna stock pops on launch of skin cancer treatment trial. Moderna (MRNA). According to Wall Street analysts, the average 1-year price target for MRNA is USD with a low forecast of USD and a high forecast of USD. Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Moderna. MRNA. Cambridge, Massachusetts. $ + (+%). Share Price. as Price to Tangible Book Value (ttm). Total Enterprise Value to EBIT . A ratio used to determine if a company's market value is in line with the value of its assets less liabilities and preferred stock. , —. Return on assets. A. MRNA | Complete Moderna Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Free Value Report. How much is Moderna Inc stock worth? Invest with precise valuations. Get Report. SIMILAR TO MRNA-Q. MRNA-Q Related Stocks. Symbol, Name. AMGN. Value Score · Upgrade · Fundamental Score · Upgrade · Valuation (Hist. Mult.) Upgrade. Profile. Moderna is a commercial-stage biotech that was founded in

Liabilities & Shareholders' Equity. All values USD Millions. , , , , , 5-year trend. Market cap: $ Billion. As of March Moderna has a market cap of $ Billion. This makes Moderna the world's th most valuable company by market. Moderna Inc (MRNA). Quotes Option Data. Last Trade: PM Mar 07, (ET) Last Price: Change: + (+%). Prices are delayed 20 minutes. Moderna Inc's intrinsic value calculated by icTracker using Intellectual Capital analysis. Moderna is undervalued with Real Value of and Target Price of At present, Moderna's Enterprise Value is projected to increase significantly.

As of , the Fair Value of Moderna Inc (MRNA) is USD. This value is based on the Peter Lynch's Fair Value formula. Mission, Vision, and Values of Moderna Therapeutics. Mission Statement: “Deliver on the promise of mRNA science to create a new generation of transformative.

j jill stock | after hours market news


Copyright 2012-2024 Privice Policy Contacts